Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 1592343)

Published in Hepatology on June 01, 1992

Authors

P R Gibson1, J R Fraser, T J Brown, C F Finch, P A Jones, J C Colman, F J Dudley

Author Affiliations

1: Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Australia.

Articles by these authors

Cellular differentiation, cytidine analogs and DNA methylation. Cell (1980) 10.15

Hyaluronan. FASEB J (1992) 6.67

Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell (1979) 6.47

Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet (1972) 5.17

5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science (1990) 4.80

The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res (1999) 4.74

Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res (1997) 4.65

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (1996) 4.54

Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med (1994) 4.34

Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res (1995) 4.28

Mandatory bicycle helmet use following a decade of helmet promotion in Victoria, Australia--an evaluation. Accid Anal Prev (1994) 4.05

Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. Cancer Res (1986) 3.95

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess (2004) 3.73

Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38

4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med (1997) 3.31

5-methylcytosine, gene regulation, and cancer. Adv Cancer Res (1983) 3.27

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med (1996) 2.94

Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res (1998) 2.83

Predicting survival using simple clinical variables: a case study in traumatic brain injury. J Neurol Neurosurg Psychiatry (1999) 2.83

Altering gene expression with 5-azacytidine. Cell (1985) 2.79

DNA methylation decreases in aging but not in immortal cells. Science (1983) 2.67

Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. Lancet (1971) 2.61

Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the "thrifty genotype". Am J Epidemiol (1991) 2.61

DNA methylation: past, present and future directions. Carcinogenesis (2000) 2.58

Cytosine methylation does not affect binding of transcription factor Sp1. Proc Natl Acad Sci U S A (1988) 2.56

The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol (1998) 2.53

p16 gene in uncultured tumours. Nature (1994) 2.47

Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Nature (1977) 2.44

The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev (2008) 2.39

Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J (1972) 2.39

The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Res (1994) 2.37

Role of intracranial pressure monitoring in severely head-injured patients without signs of intracranial hypertension on initial computerized tomography. J Neurosurg (1994) 2.36

Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res (2001) 2.27

Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. Genes Dev (1992) 2.19

Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev (2005) 2.17

Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst (2001) 2.13

Effect of disinfectants on pathogenic free-living amoebae: in axenic conditions. Appl Environ Microbiol (1980) 2.08

High frequency mutagenesis by a DNA methyltransferase. Cell (1992) 2.08

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst (1998) 2.07

Management of haematemesis and melaena. Med J Aust (1997) 2.05

High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabetes (1990) 2.01

Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages. J Exp Med (1980) 2.00

How valid is a self reported 12 month sports injury history? Br J Sports Med (2003) 1.93

Mechanism of action of eukaryotic DNA methyltransferase. Use of 5-azacytosine-containing DNA. J Mol Biol (1982) 1.89

Rapid diagnosis of bacteremia by universal amplification of 23S ribosomal DNA followed by hybridization to an oligonucleotide array. J Clin Microbiol (2000) 1.88

PAX6 methylation and ectopic expression in human tumor cells. Int J Cancer (2000) 1.87

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol (1993) 1.85

Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci (1997) 1.84

Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. Proc Natl Acad Sci U S A (1982) 1.84

The structure and function of hyaluronan: An overview. Immunol Cell Biol (1996) 1.84

Culture of synovial cells in vitro. Notes on isolation and propagation. Ann Rheum Dis (1965) 1.83

Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum Mol Genet (2001) 1.83

Phenotypic conversion of cultured mouse embryo cells by aza pyrimidine nucleosides. Dev Biol (1978) 1.76

Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol Cell Biol (1994) 1.74

A psychogeriatric survey of old people's homes. Br Med J (Clin Res Ed) (1981) 1.74

Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res (1983) 1.74

The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res (1998) 1.73

Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells. Nucleic Acids Res (2000) 1.73

Changes in the allelic methylation patterns of c-H-ras-1, insulin and retinoblastoma genes in human development. Dev Suppl (1990) 1.73

DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J Biol Chem (1986) 1.72

Use of cell cultures as an indicator of pathogenicity of free-living amoebae. J Clin Pathol (1978) 1.72

Glycoprotein, elastin, and collagen secretion by rat smooth muscle cells. Proc Natl Acad Sci U S A (1979) 1.71

Hemimethylated duplex DNAs prepared from 5-azacytidine-treated cells. Nucleic Acids Res (1981) 1.70

Inhibition of DNA methylation by chemical carcinogens in vitro. Cell (1983) 1.68

Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res (1990) 1.67

Involvement of DNA methylation in human carcinogenesis. Biol Chem (1998) 1.65

Head injury in the elderly. Age Ageing (1986) 1.65

Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol (2000) 1.64

On the pericellular zone of some mammalian cells in vitro. Exp Cell Res (1968) 1.63

Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol Cell Endocrinol (1997) 1.62

Immunological studies in an epidemic of infective, short-incubation hepatitis. Lancet (1972) 1.62

Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen. Lancet (1972) 1.60

Scar formation after stereotactic vacuum-assisted core biopsy of benign breast lesions. Clin Radiol (2006) 1.60

Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells. Cancer Res (1980) 1.59

Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet (1972) 1.59

Hepatic hydrothorax in the absence of clinical ascites: diagnosis and management. Gastroenterology (1985) 1.58

Prescription of oxygen concentrators: adherence to published guidelines. Thorax (1989) 1.57

Long latency pneumonia: a case of melioidosis. J Infect (1990) 1.54

Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J (1981) 1.53

Microbes, peptic ulcer, and relapse rates with different drugs. Lancet (1984) 1.51

Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res (1997) 1.51

DNA methylation differences associated with tumor tissues identified by genome scanning analysis. Genomics (1998) 1.51

Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res (1996) 1.51

HhaI and HpaII DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair. Nucleic Acids Res (1995) 1.50

Concentration and relative molecular mass of hyaluronate in lymph and blood. Biochem J (1986) 1.50

Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J (1984) 1.50

Zebularine: a new drug for epigenetic therapy. Biochem Soc Trans (2004) 1.49

Roles of cell division and gene transcription in the methylation of CpG islands. Mol Cell Biol (1999) 1.49

Fibrinolytic activity in a human fibrosarcoma cell line and evidence for the induction of plasminogen activator secretion during tumor formation. Cell (1975) 1.48

Sport, age, and sex specific incidence of sports injuries in Western Australia. Br J Sports Med (2000) 1.48

Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis. Ann Intern Med (1997) 1.47

DNA methylation and cancer. Cancer Res (1986) 1.47

Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. Antimicrob Agents Chemother (2005) 1.45

Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Res (1993) 1.44

Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol (1991) 1.44

Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis (1997) 1.43

Glasgow Outcome Scale: an inter-rater reliability study. Brain Inj (1993) 1.42

Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess (2006) 1.41

Change in serum hyaluronan: a simple index of short-term drug-induced changes in hepatic sinusoidal perfusion. Gastroenterology (1993) 1.41